08/21/2024 5:19 PM | Cytek Biosciences (Issuer) Poirson Allen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2024 5:21 PM | Cytek Biosciences (Issuer) Williams Paul Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2024 5:22 PM | Cytek Biosciences (Issuer) Yan Ming (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2024 5:24 PM | Cytek Biosciences (Issuer) Jiang Wenbin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2024 5:26 PM | Barnett Valerie (Reporting) Cytek Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2024 5:28 PM | Cytek Biosciences (Issuer) Holder Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2024 5:15 PM | Busque Philippe (Reporting) Cytek Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
08/06/2024 4:16 PM | Cytek Biosciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/06/2024 3:16 PM | Cytek Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/07/2024 5:51 PM | Cytek Biosciences (Issuer) HARDISON DON M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 5:53 PM | Cytek Biosciences (Issuer) Imper Vera (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 5:59 PM | Cytek Biosciences (Issuer) NEFF DEBORAH J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 6:03 PM | Ball Jack (Reporting) Cytek Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 6:05 PM | Cytek Biosciences (Issuer) Holder Michael (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
06/07/2024 6:09 PM | Cytek Biosciences (Issuer) Holder Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2024 3:48 PM | Cytek Biosciences (Filer)
| Form SD Specialized Disclosure Report | |
05/22/2024 5:36 PM | Cytek Biosciences (Issuer) Yan Ming (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/22/2024 5:41 PM | Cytek Biosciences (Issuer) Poirson Allen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/22/2024 5:28 PM | Busque Philippe (Reporting) Cytek Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/22/2024 5:31 PM | Barnett Valerie (Reporting) Cytek Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/22/2024 5:32 PM | Cytek Biosciences (Issuer) Jiang Wenbin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/22/2024 5:34 PM | Cytek Biosciences (Issuer) Williams Paul Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2024 6:19 PM | Cytek Biosciences (Issuer) McCombe William D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/25/2024 3:26 PM | Cytek Biosciences (Filer)
| Form ARS | |
04/23/2024 5:07 PM | Cytek Biosciences (Issuer) Yan Ming (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/11/2024 5:17 PM | Cytek Biosciences (Issuer) Yan Ming (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/09/2024 3:21 PM | Cytek Biosciences (Subject) Yan Ming (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/21/2024 5:19 PM | Busque Philippe (Reporting) Cytek Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 7:27 PM | Cytek Biosciences (Issuer) McCombe William D. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
03/19/2024 5:25 PM | Cytek Biosciences (Issuer) Yan Ming (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2024 3:35 PM | Cytek Biosciences (Subject) Yan Ming (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2024 5:53 PM | Cytek Biosciences (Issuer) Williams Paul Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 5:55 PM | Cytek Biosciences (Issuer) Yan Ming (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 5:44 PM | Cytek Biosciences (Issuer) Jeanmonod Patrik (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 5:48 PM | Cytek Biosciences (Issuer) Jiang Wenbin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 5:50 PM | Cytek Biosciences (Issuer) Poirson Allen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 5:39 PM | Barnett Valerie (Reporting) Cytek Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 3:42 PM | Cytek Biosciences (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/08/2024 5:44 PM | Barnett Valerie (Reporting) Cytek Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 5:46 PM | Busque Philippe (Reporting) Cytek Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 5:47 PM | Cytek Biosciences (Issuer) Jiang Wenbin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Tim Sykes’ Urgent Trade Alert: “Make this move now” (Ad) WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock
This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9318&Placement=NativeDisplay&Source=NativeDisplay) Click here to see a unique election-year trade |
03/08/2024 5:49 PM | Cytek Biosciences (Issuer) Poirson Allen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 5:51 PM | Cytek Biosciences (Issuer) Williams Paul Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 5:52 PM | Cytek Biosciences (Issuer) Yan Ming (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 3:05 PM | Cytek Biosciences (Filer)
| Form NT 10-K | |
03/01/2024 5:06 AM | Cytek Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/27/2024 5:06 AM | Cytek Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/22/2024 6:07 PM | Cytek Biosciences (Subject) RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
02/22/2024 4:37 PM | Barnett Valerie (Reporting) Cytek Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/22/2024 4:46 PM | Cytek Biosciences (Issuer) Jiang Wenbin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/22/2024 4:49 PM | Cytek Biosciences (Issuer) Williams Paul Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/22/2024 4:50 PM | Cytek Biosciences (Issuer) Yan Ming (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/22/2024 4:32 PM | Cytek Biosciences (Issuer) Poirson Allen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/22/2024 4:34 PM | Cytek Biosciences (Issuer) Jeanmonod Patrik (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 2:12 PM | BROWN CAPITAL MANAGEMENT LLC (Filed by) Cytek Biosciences (Subject)
| Form SC 13G | |
01/23/2024 3:13 PM | BlackRock Inc. (Filed by) Cytek Biosciences (Subject)
| Form SC 13G/A | |
01/09/2024 5:05 AM | Cytek Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/27/2023 4:36 PM | Cytek Biosciences (Issuer) Jeanmonod Patrik (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/21/2023 4:35 PM | Cytek Biosciences (Issuer) Yan Ming (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/19/2023 3:28 PM | Cytek Biosciences (Subject) Yan Ming (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/28/2023 6:00 AM | Cytek Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/27/2023 7:48 PM | Cytek Biosciences (Issuer) Yan Ming (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/27/2023 7:53 PM | Cytek Biosciences (Issuer) Jeanmonod Patrik (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2023 4:56 PM | Cytek Biosciences (Issuer) Williams Paul Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2023 4:59 PM | Cytek Biosciences (Issuer) Yan Ming (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2023 4:46 PM | Barnett Valerie (Reporting) Cytek Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2023 4:48 PM | Cytek Biosciences (Issuer) Jiang Wenbin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2023 4:52 PM | Cytek Biosciences (Issuer) Jeanmonod Patrik (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2023 4:54 PM | Cytek Biosciences (Issuer) Poirson Allen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/14/2023 3:39 PM | Cytek Biosciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/09/2023 5:06 AM | Cytek Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/08/2023 5:03 PM | Cytek Biosciences (Issuer) Jiang Wenbin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/07/2023 3:45 PM | Cytek Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/25/2023 5:29 PM | Cytek Biosciences (Issuer) Jeanmonod Patrik (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/23/2023 7:36 PM | Cytek Biosciences (Issuer) Yan Ming (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/19/2023 3:02 PM | Cytek Biosciences (Subject) Yan Ming (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/11/2023 6:25 PM | Cytek Biosciences (Issuer) Jiang Wenbin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/05/2023 7:32 PM | Cytek Biosciences (Issuer) Jiang Wenbin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/26/2023 5:42 PM | Cytek Biosciences (Issuer) Jeanmonod Patrik (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/20/2023 5:27 PM | Cytek Biosciences (Issuer) Yan Ming (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2023 4:25 PM | Cytek Biosciences (Subject) RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
09/08/2023 6:12 PM | Cytek Biosciences (Issuer) Jiang Wenbin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/07/2023 3:15 PM | Cytek Biosciences (Subject) Jiang Wenbin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |